chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: HPV4
Symptoms: Dyspnoea
Clinical narrative: Information has been received from physician concerning a female patient who was vaccinated with a 0.5 ml dose of GARDASIL vaccine. The patient experienced shortness of breath 24 hours after receiving GARDASIL vaccine. At the time of reporting the patient was recovered. The patient sought medical attention. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Flank pain, Hyperventilation, Muscle spasms, Pain, Tenderness
Clinical narrative: This is in follow-up to report (s) previously submitted on 02/13/2009. Information has been received from a physician concerning a 16 year old female who on 15-JAN-2009 was vaccinated with a 0.5 ml dose of GARDASIL vaccine. Subsequently (on 15-JAN-2009) the patient experienced severe muscle spasms in right flank above hip into back, and pain and tenderness to touch. Symptoms started 15 to 20 minutes after leaving the office. At the time of the report, 15-JAN-2009, the patient was reportedly recovering. No further information was provided. The patient sought medical attention. Follow up information was received from a physician concerning the 16 year old female patient with no pre-existing allergies, birth defects, or medical conditions who on 15-JAN-2009 was vaccinated intramuscularly in the left deltoid with her first dose of GARDASIL (lot# 60555/0279X). There was no illness at the time of vaccination and adverse event following prior vaccination. On 15-JAN-2009 at 2:30 PM the patient experienced right flank pain, "sharp" and constant, exacerbated by deep breaths. The patient was recovered on 16-JAN-2009. No relevant diagnostic tests or laboratory data was collected. The patient sought unspecified medical attention. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection
Clinical narrative: Information has been received from a 19 year old female with no drug allergy who in January 2008 was vaccinated with the first dose of GARDASIL. She stated she had all 3 doses. On 15-JAN-2009 the patient was told she had papilloma viral infection. No medical attention was sought. At the time of reporting, the patient's HPV infection persisted. No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Pelvic pain
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with a third dose of GARDASIL vaccine and experienced pelvic pain. Unspecified medical attention was sought. At the time of reporting, the patient's outcome was unspecified.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Alopecia
Clinical narrative: Information has been received from a registered nurse concerning a 20 year old female who on 09-OCT-2008 was vaccinated with the first  0.5 ml dose of GARDASIL vaccine (lot#661764?0650X). There was no concomitant medication. One week later after getting GARDASIL vaccine the patient developed alopecia, she would not be taking any more doses of GARDASIL vaccine. At the time of reporting, the outcome was unknown. No additional information was provided. The patient sought unspecified medical attention. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, HIV antibody positive, Hepatitis B antibody negative, Immunology test, Laboratory test
Clinical narrative: Information has been received from a nurse concerning a 19 year old female patient for the pregnancy registry for GARDASIL. With allergy to BENADRYL, who on 03-Feb-2008 was vaccinated with the first dose of GARDASIL. On an unspecified date the patient received the second dose GARDASIL. Concomitant therapy included prenatal vitamins. She was determined to be pregnant. Last menstrual period: 27-Jun-2008. Estimated delivery date: 03-Apr-2009. In October 2008, she tested positive for HIV ELTSA test and negative for HIV western blot test. In December 2008 she tested undetermined for HIV western blot
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Syphilis test negative
Clinical narrative: Information has been received from a nurse concerning a 19 year old female patient for the pregnancy registry for GARDASIL. With allergy to BENADRYL, who on 03-Feb-2008 was vaccinated with the first dose of GARDASIL. On an unspecified date the patient received the second dose GARDASIL. Concomitant therapy included prenatal vitamins. She was determined to be pregnant. Last menstrual period: 27-Jun-2008. Estimated delivery date: 03-Apr-2009. In October 2008, she tested positive for HIV ELTSA test and negative for HIV western blot test. In December 2008 she tested undetermined for HIV western blot
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Hypoaesthesia, Muscular weakness, Paraesthesia, Throat tightness
Clinical narrative: Information has been received from a physician and her assistant concerning  23 year old female who on an unknown date was vaccinated with a first dose of GARDASIL vaccine and a second dose of GARDASIL vaccine on 12-JAN-2009, lot number 661766/0652X. It was reported that the patient experienced dizziness and blurry vision after receiving the first dose of GARDASIL vaccine. On 12-JAN-2009 the patient felt like her throat was closing and took BENADRYL. On 14-JAN-2009 the patient called the office and reported her left leg and arm were numb, right hand was tingling and she was still experiencing intermittent blurry vision. The physician prescribed ZYRTEC for the next week to treat what she feels may be an allergic reaction to the vaccine. Her outcome is unknown. Follow-up information received from physician's assistant indicated that the patient was vaccinated with the first dose of GARDASIL vaccine on 28-OCT-2008, lot number 661530/0575X. Concomitant medication include FENCOM for birth control. It was reported that the patient called the office on 15-JAN-2008 to report that she was experiencing hives. Follow up information was received from the physician who noted that the patient has a long-standing "histrionic personality" and an anxiety disorder for which she takes KLONOPIN as needed. She claims to have experienced some throat tightness after dose 1, but did not report this to her physician until after his occurred with dose 2. She has had multiple symptoms of numbness, tingling and weakness of the extremities (of note, the injection was given in the right arm but complaining have been on the left side initially, then bilaterally); however, she has been able to go to work as a hairdresser. Since the development of hives, the patient has not been seen in the office and has not responded to phone messages from the physician's office. No further doses of GARDASIL are planned, given the concern about hypersensitivity. Follow-up information received from her physician indicated that the patient called the office on 15-JAN-2008 to report that she had hives and then called the office again on 16-JAN-2008 to report that she did not have hives. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Urticaria, Vision blurred
Clinical narrative: Information has been received from a physician and her assistant concerning  23 year old female who on an unknown date was vaccinated with a first dose of GARDASIL vaccine and a second dose of GARDASIL vaccine on 12-JAN-2009, lot number 661766/0652X. It was reported that the patient experienced dizziness and blurry vision after receiving the first dose of GARDASIL vaccine. On 12-JAN-2009 the patient felt like her throat was closing and took BENADRYL. On 14-JAN-2009 the patient called the office and reported her left leg and arm were numb, right hand was tingling and she was still experiencing intermittent blurry vision. The physician prescribed ZYRTEC for the next week to treat what she feels may be an allergic reaction to the vaccine. Her outcome is unknown. Follow-up information received from physician's assistant indicated that the patient was vaccinated with the first dose of GARDASIL vaccine on 28-OCT-2008, lot number 661530/0575X. Concomitant medication include FENCOM for birth control. It was reported that the patient called the office on 15-JAN-2008 to report that she was experiencing hives. Follow up information was received from the physician who noted that the patient has a long-standing "histrionic personality" and an anxiety disorder for which she takes KLONOPIN as needed. She claims to have experienced some throat tightness after dose 1, but did not report this to her physician until after his occurred with dose 2. She has had multiple symptoms of numbness, tingling and weakness of the extremities (of note, the injection was given in the right arm but complaining have been on the left side initially, then bilaterally); however, she has been able to go to work as a hairdresser. Since the development of hives, the patient has not been seen in the office and has not responded to phone messages from the physician's office. No further doses of GARDASIL are planned, given the concern about hypersensitivity. Follow-up information received from her physician indicated that the patient called the office on 15-JAN-2008 to report that she had hives and then called the office again on 16-JAN-2008 to report that she did not have hives. Additional information has been requested.
Age: 22.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection, Smear cervix abnormal, Viral DNA test positive
Clinical narrative: Information has been received from a Nurse Practitioner concerning a 22 year old female virgin patient with no pertinent medical history no drug reactions or allergy who on 07-JUN-2007 was vaccinated with first dose of GARDASIL vaccine (lot # not reported) 0.5ml, intramuscularly. On 09-AUG-2007 patient received second dose of GARDASIL vaccine (lot # not reported) 0.5ml, intramuscularly and on 30-NOV-2007 she received third dose of GARDASIL vaccine (lot # 659439/1267U) 0.5ml, intramuscularly. Concomitant therapy included hormonal contraceptives (unspecified). Patient was virgin prior GARDASIL vaccination. In December 2008 the patient had an abnormal pap and DNA test was positive for high risk HPV. Patient sought medical attention was seen in the office. This is one of two reports from the same source. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Injection site mass, Injection site pain
Clinical narrative: Information has been received from a registered nurse concerning a female, who was vaccinated with the second dose of GARDASIL, IM in upper deltoid, single dose vial. Subsequently the patient experienced an injection site reaction which included a lump and soreness about 4-5 days after receiving the vaccine. The patient sought medical attention. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Erythema, Pruritus, Rash
Clinical narrative: Information has been received from a nurse practitioner concerning a 16 year old female patient with penicillin allergy, who on 14-JAN-2009 was vaccinated with the first 0.5 mL dose of GARDASIL (Lot # 661530/0575X). On 15-JAN-2009 the patient experienced a rash on her wrist and up her arm. The patient sought unspecified medical attention. There were no laboratory or diagnostic tests performed. The patient recovered on 16-JAN-2009. Follow up information received from the medical assistant on 26-JAN-2009. It was reported that the 16 year old female patient with penicillin allergy that caused rash, on 14-JAN-2009 was vaccinated into the left deltoid with the first 0.5 mL dose of GARDASIL. On 15-JAN-2009, the patient experienced a mild rash to hands and lower forearm areas bilaterally, slight erythema that had pruritis. The symptoms started to resolved and then returned after shower. The patient denied any changes to medication, powders, soaps, lotions and/or detergents. The patient did not require treatment. Additional information is not expected.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, No reaction on previous exposure to drug, Syncope
Clinical narrative: Information has been received from a consumer concerning her 15 year old female daughter with no pertinent medical history and no drug reactions/allergies, who on 20-MAR-2008 was vaccinated with the first 0.5mL dose of GARDASIL. There was no concomitant medication. On 26-AUG-2008 her daughter fainted after getting second dose of GARDASIL and on the same day patient recovered. The reported stated that her daughter did not experience any adverse event after getting first dose of GARDASIL. The patient sought unspecified medical attention. No further information is available.
Sex: U
Vaccine: HPV4
Symptoms: Injection site pain, Vaccine positive rechallenge
Clinical narrative: Information has been received from a nurse concerning "almost every single patient" (approximately 237) who was vaccinated with GARDASIL.  Subsequently the patients complained of injection site pain after the first, second and third doses of GARDASIL.  It was unknown if the patients sought medical attention.  This is one of several reports from the same source.  Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site haematoma, Injection site pain, Injection site swelling, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a medical assistant concerning a 17 year old female with no pertinent medical history who on 30-OCT-2008 was vaccinated with the first dose of GARDASIL, on 8-JAN-2009 was vaccinated with the second dose of GARDASIL (LOT# 0947X) IM into the left deltoid.  There was no concomitant medication.  On 12-JAN-2009, the patient had an injection site reaction including swelling, pain and bruising after vaccination with her 2nd dose of GARDASIL.  The patient's injection site reaction including swelling, pain and bruising persisted. The patient did not have an AE after her first dose.  it was reported that the patient sought medical attention:  phone call.  Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Syncope
Clinical narrative: Information has been received from a nurse practitioner concerning a female who was vaccinated with a dose of GARDASIL (lot # not reported). Subsequently the patient fainted. The outcome was unknown. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site pain
Clinical narrative: Information has been received from a Certified Medical Assistant concerning an approximately 14-year-old female with no known drug allergies who was vaccinated intramuscularly with her first 0.5 ml dose of GARDASIL vaccine (655604/0052X) abut three weeks ago (approximately December 2008). The patient experienced pain at the injection site during administration of GARDASIL vaccine. The patient was recovered. This is the second of two patients for reporter. The patient sought medical attention. Addition information has been requested.  Follow up information was received from a Certified Medical Assistant concerning the 14 year old female patient who on 04-JAN-2009 was vaccinated intramuscularly in the left deltoid with her first dose of GARDASIL (lot# 655604/0052X). She reported that "there was no adverse reaction just painful at time of injectiob than normal shot due to prefilled syringe of GARDASIL caused rough exiting of injection". The spring caused painful exit of needle. The patient was fine with no problems after injection.   The patient sought unspecified medical attention.  No further information is available.
Sex: F
Vaccine: HPV4, MEN
Symptoms: Syncope
Clinical narrative: Information has been received from a nurse practitioner concerning her daughter who in October 2008, was vaccinated the first dose of GARDASIL. Concomitant therapy included meningococcal vaccine. In October 2008 after she received the dose , the patient experienced fainted. Subsequently  the patient recovered. It is unknown if the patient sought medical attention. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Sensation of heaviness
Clinical narrative: Information has been received from a physician concerning a 15 year old female who was vaccinated with a 0.5ml dose of GARDASIL (lot number not provided) on an unspecified date. After receiving GARDASIL she experienced a "heavy arm". It was unknown which arm was affected. The outcome was unknown at the time of reporting. The patient sought unspecified medical attention. Additional information has been requested.
Age: 26.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Headache, Vision blurred
Clinical narrative: Information has been received from a registered nurse concerning her 26 year old daughter who on 13-JAN-2000 was vaccinated with a second dose of GARDASIL 0.5 ml. There was no concomitant medication. After a couple of hours the patient experienced dizziness, horrible headache and blurry vision. At the night of 13-JAN-2009 ("last night") the patient recovered. The patient sought medical attention of the nurse is also her mother. Additional information has been requested.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Musculoskeletal stiffness, Neck pain, Pain in extremity
Clinical narrative: Information has been received from a nurse concerning a 14 year old female student patient who on 12-JAN-2009 was vaccinated with the third dose of GARDASIL (LOT # 661841/0653X). Concomitant therapy included CIPRODEX. It was reported that the patient woke up on 14-JAN-2008 with a pain in her arm that goes up to her neck making her have a stiff neck. She also head pain, "but is not a headache". The nurse also reported that the patient did not have any swollen glands and did not have a fever, but the patient had taken TYLENOL and went to school. The nurse also stated that the patient did not have any problems after receiving the first and second dose of GARDASIL. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Headache
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL (Lot # was not available) experienced severe headaches after receiving the vaccine.  The patient went to emergency room because of these headaches but it was not known if she was admitted to the hospital.  The patient sought unspecified medical attention.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 02/13/09. Follow up information was received. On 05-Jan-2009 the 19 year old female was vaccinated with her first dose of GARDASIL (Lot # 660616/0570X, route not reported) into her right deltoid. Sometime between 05-JAN-2009 and 14-JAN-2009 the patient developed severe headaches. Subsequently the patient recovered from the severe headaches. The event was not disabling. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: Vomiting
Clinical narrative: Information has been received from a nurse concerning a 25 year old female patient with no known drug reactions/allergies and medical history who on 07-JAN-2009 was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (Lot #661530/0575X).  Concomitant therapy included LEVORA.  The nurse reported that the patient began vomiting 2.5 to 3 hours after administration the vaccine.  The patient vomited through that night and the next day.  The physician prescribed PHENERGAN for the patient which were effective in treating the symptom.  The patient sought medical attention by phone.  The patient recovered on 09-JAN-2009.  Additional information has been requested. This is in follow-up to report(s) previously submitted on 2/13/2009. Follow up has been received from the nurse who reported that the patient completely recovered in 24 hours and she did not think the patient was willing to continue the vaccination series with GARDASIL. No additional was reported. Follow up has been received from the nurse who reported that the patient was vaccinated with her first dose in her right arm at 15:50 p.m. The patient had no pre-existing conditions or illness at the time of vaccination. The vomiting started at 18:00 p.m. The patient was prescribed promethazine 30 mg suppositories. No additional information was reported.
Sex: F
Vaccine: HPV4
Symptoms: Inappropriate schedule of drug administration, Pallor, Vomiting
Clinical narrative: Information has been received from a female patient, with no known drug reactions/allergies and no pertinent medical history, who was vaccinated with three doses of GARDASIL. There was no concomitant medication. The consumer stated she is seeing a new doctor and the doctor provided her with a fourth dose of GARDASIL. She also mentioned she vomited and turned pale white taking the doses of GARDASIL. No further information is available.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Arrhythmia, Palpitations, Tachycardia
Clinical narrative: This is in follow-up to report (s) previously submitted on 02/13/2009. Information has been received from a licensed practical nurse concerning a 19 year old female patient with no known medical history; who on 20-AUG-2008 was vaccinated with a 0.5 ml second dose of GARDASIL vaccine, intramuscularly. There was no concomitant medication. The patient developed tachycardia after she received the GARDASIL vaccine. The patient sought medical attention through a cardiologist visit. Additional information has been requested. Follow up information received on 04-MAR-2009 from the licensed practical nurse, stated that the patient received the first dose GARDASIL on 19-JUN-2008 (previously reported on 20-JAN-2008) (lot # 654272/0073X) and second dose of GARDASIL on 20-AUG-2008 (lot # 654272/0073X). The patient has a follow up appointment with the physician on 14-JAN-2009 and the patient stated that she began having palpitations after she received the second of GARDASIL. The exact onset date was not reported. It was documented that the patient was experiencing tachyarrhythmia. The patient was not admitted to the hospital. The patient was seen by a cardiologist. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HEPA, HPV4
Symptoms: Discomfort, Dysuria, Hypoaesthesia, Paraesthesia
Clinical narrative: Information has been received from a nurse practitioner concerning a 19 year old female who on 08-Jan-2009 was vaccinated with the first dose of GARDASIL lot number 661766 /0652X, 0.5ml, intramuscularly into the right deltoid. The patient also received her second dose of Hepatitis A virus vaccine. Other concomitant therapy included YAZ. It was reported that on 08-Jan-2009 in the evening, the patient developed numbness and tingling in her legs from the knees down. The patient stated to the nurse practitioner that the discomfort has gotten worse every day and when she laid down she developed numbness and discomfort starting at her sacrum and continuing down her legs. The nurse practitioner also mentioned that the patient was having difficulty urinating. The nurse practitioner reported that the patient had not sustained any injury. At the time of the report, the patient had not recovered. On 13-Jan-2008, the patient was seen in the office. Additional information has been requested.  3/3/09 Received vaccine record & GYN records of 1/8-1/13/2009. FINAL DX: none provided. Records reveal patent in good health on 1/8.  RTC 1/13 w/dysuria & hesitancy x 3 days and legs tingling/numbness since 1/8.  Referred to PCP.  Calls to patient after 1/13 not returned.  3/24/09 Received additional GYN records of 2/26/09. Patient returned to clinic for hormon implantation birth control.
Sex: F
Vaccine: HPV4
Symptoms: Biopsy, No reaction on previous exposure to drug, Smear cervix abnormal
Clinical narrative: Information has been received from a physician concerning a female patient who on vaccinated with the three doses of GARDASIL. Shortly after the third dose she developed an abnormal pap smear. The patient sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Injection site pain
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with a dose of GARDASIL last fall and said the vaccine hurt so much. This is one of three reports from the same source. Additional information has been requested.
Age: 18.0
Sex: F
Vaccine: HPV4
Symptoms: Injection site discolouration, Vaccine positive rechallenge
Clinical narrative: Information has been received from a licensed practical nurse concerning an 18 year old female patient with no known medical history and drugs allergies, who on 15-Sep-2008 was vaccinated with a first dose of GARDASIL ,  (lot # 0053X),  intramuscularly. On 17-Nov-2008 the patient received a second dose of GARDASIL (lot#0702X),Intramuscularly. There was no concomitant medication. After both doses the patient developed a "white flat halo " around the injection site. The first halo was not noticed until the patient noticed until the second halo. At the time of this report the patient had not recovered. The patient sought medical attention through an office visit. Additional information has been requested
Sex: F
Vaccine: HPV4
Symptoms: Headache, No reaction on previous exposure to drug
Clinical narrative: Information has been received from a nurse Concerning a female who was vaccinated with the third dose of GARDASIL vaccine.  The nurse reported that "the patient received the third dose of GARDASIL and then 24 hours later the patient's mom called the nurse and told her the patient had a headache".  The nurse stated that she advised the patient's mother to speak to the patient's physician.  The patient did not seek medical attention.  Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Neuropathy peripheral
Clinical narrative: Information has been received from a physician concerning a female patient with unspecified psychiatric problems and restless legs syndrome who in December 2007 was vaccinated with a dose of GARDASIL vaccine (Lot not reported). Recently the patient was diagnosed with peripheral neuropathy. The patient sought medical attention at the office. As of 13-JAN-2009 the outcome of the patient was unknown. Additional information has been requested.
Age: 25.0
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Pain in extremity, Urticaria
Clinical narrative: Information has been received from a nurse practitioner concerning a 25 year year old female patient with no pertinent medical history, not known drug reactions/allergies who on 01-JUL-2008 was vaccinated intramuscularly with the first GARDASIL vaccine, on 02-SEP-2008 was vaccinated intramuscularly with the second 0.5 mL dose of GARASIL vaccine.  The patient did not have any adverse effects after the first or the second dose.  On an unspecified date, in approximately 2008 the patient was vaccinated intramuscularly with the third 0.5 mL dose of GARDASIL vaccine.  Subsequently the patient developed "achiness" in the injection arm 24 hours after her third dose of GARDASIL vaccine.  The nurse practitioner mentioned that patient had not sustained any injury.  The patient was sent to see an allergist since she had developed hives on approximately 13-NOV-2008, "2 months ago".  The patient's hives were treated with ZYRTEC.  While seeing the allergist the patient mentioned the "achiness" to her arm.  The allergist recommended that the patient saw her primary care provider since he felt it was "a drug reaction".  The patient was seen on 12-JAN-2009 and the nurse practitioner stated she was able to reproduce the discomfort by "pressing down inside elbow and the patient experienced tingling in three of her fingers".  The nurse practitioner mentioned "I did not believe that this is caused by GARDASIL vaccine and there was something else going on".  At the time of reporting, the patient had not recovered.  Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Chest pain, Panic attack, Respiratory rate increased, Vaccine positive rechallenge
Clinical narrative: Information has been received from a physician assistant concerning a 15 or 16 year old female patient who on unknown dates was vaccinated with a first and second dose of GARDASIL, lot number not specified. Approximately 2 weeks after the dose was given the patient experienced "panic attack", where she felt pain in her chest and rapid breathing, it happened after both doses of GARDASIL. The assistant stated that the Dr. advised not to get the 3rd dose of GARDASIL. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Skin haemorrhage
Clinical narrative: Information has been received from a registered nurse concerning her daughter who was vaccinated with the third dose of GARDASIL.  Four days after the third dose the patient experienced bleed in her arm.  It did not happen with the previous dose.  At the time of reporting, the outcome was unknown.  It is unknown if the patient sought medical attention.  Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Syncope
Clinical narrative: Information has been received from a physician concerning a female who on unspecified date was vaccinated with a first dose of GARDASIL and had syncope. The physician did not specify if the patient fully fainted. After the second dose of GARDASIL on unspecified date, the patient felt dizzy. The physician reported that the patient then received the third dose of GARDASIL on unspecified date but they had her lay down to receive the vaccine and no experience was reported. The patient sought medical attention to the physician. Additional information has been requested.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Syncope
Clinical narrative: Information has been received from a physician concerning a 13 year old female patient, who on unspecified dates, was vaccinated with the second dose of GARDASIL, 0.5ml.  The patient had a rash on stomach from insect bite at the time of vaccination.  The physician reported that in November 2008, the patient experienced syncope after receiving the second dose of GARDASIL.  The patient recovered the same day.  The patient sought unspecified medical attention.  Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Joint swelling, Oedema peripheral, Pruritus, Urticaria
Clinical narrative: Information has been received from a nurse concerning a female who was vaccinated with a first dose of GARDASIL. The patient called the nurse 4 to 5 weeks ago (approximately December 2008) and reported that she experienced swelling of her wrist and palm of her hands, the sole of her feet were very itchy, and had welt or hives on her hips and one breast. No additional information is available.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Asthenia, Blood glucose normal, Depressed level of consciousness, Dizziness, Electrocardiogram normal
Clinical narrative: Information has been received from a registered nurse concerning a 23 year old female patient with no pertinent medical history and no known drug allergies who on 24-DEC-2008 was vaccinated with the first IM dose of GARDASIL vaccine (lot# 0947X). Concomitant therapy included calcium (unspecified), vitamins (unspecified) and DESOGEN. On 24-DEC-2008 the patient experienced felt dizzy 3 minutes and lay down. The patient became frail and unresponsive for 20-30 seconds. her pupils were equal, dilated and reactive to light. Her blood pressure was 100/50, pulse was 52, and had shallow breathing. About 2-3 minutes after being responsive, the patient fell back into a state of unresponsiveness and was difficult to arouse, This lasted for a few minutes and then she became fully alert. The emergency medical services were called and the patient was given juice boxes and bagel. EKG was normal and blood sugar after the food intake was 112. On 24-DEC-2008 the patient recovered from the adverse events. Additional information has been requested.
Age: 23.0
Sex: F
Vaccine: HPV4
Symptoms: Hypoventilation, Immediate post-injection reaction, Unresponsive to stimuli
Clinical narrative: Information has been received from a registered nurse concerning a 23 year old female patient with no pertinent medical history and no known drug allergies who on 24-DEC-2008 was vaccinated with the first IM dose of GARDASIL vaccine (lot# 0947X). Concomitant therapy included calcium (unspecified), vitamins (unspecified) and DESOGEN. On 24-DEC-2008 the patient experienced felt dizzy 3 minutes and lay down. The patient became frail and unresponsive for 20-30 seconds. her pupils were equal, dilated and reactive to light. Her blood pressure was 100/50, pulse was 52, and had shallow breathing. About 2-3 minutes after being responsive, the patient fell back into a state of unresponsiveness and was difficult to arouse, This lasted for a few minutes and then she became fully alert. The emergency medical services were called and the patient was given juice boxes and bagel. EKG was normal and blood sugar after the food intake was 112. On 24-DEC-2008 the patient recovered from the adverse events. Additional information has been requested.
Age: 43.0
Sex: F
Vaccine: HPV4
Symptoms: Papilloma viral infection
Clinical narrative: This is in follow-up to report(s) previously submitted on 2/13/2009. Information has been received from a nurse in the physician's office concerning a 43 year old female who was vaccinated with three doses of GARDASIL and was diagnosed with papilloma viral infection (HPV)shortly afterward. Papanicolaou (PAP) smear was performed (result not reported). At the time of reporting the patient's outcome was unspecified. No further information is available.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Immediate post-injection reaction, No reaction on previous exposure to drug, Syncope
Clinical narrative: Information has been received from a physician's assistant concerning a 15 year old white female, 75.9 kg and 157cm in height, who on unspecified dates was vaccinated with the first and the second doses of GARDASIL vaccine, intramuscularly, and on 08-JAN-2009 at approximately 11:30 AM, was vaccinated with the third dose of GARDASIL, intramuscularly (Lot # 661044/0548X).  The patient had sinusitis and laryngitis at the time of vaccination.  The physician's assistant reported that on 08-JAN-2009, the patient experienced syncope within 1-2 minutes after receiving immunization.  She reported that it was followed by full and complete recovery on 08-JAN-2009.  The patient was observed in clinic by parent, medical and nursing staff and left after appropriate interval on foot.  No further information is available.
Sex: F
Vaccine: HPV4
Symptoms: Rectal discharge
Clinical narrative: Information has been received from a consumer concerning her daughter who was vaccinated with the third dose of GARDASIL.  In January 2009 ("a couple of days ago"), the patient experienced an oily discharge that appeared to be green in color leaking from her rectum.  At the time of this report, the outcome was unknown.  The patient did not seek medical attention and the reporter stated that she would be contacting her daughter's doctor.  No further information is available.
Age: 14.0
Sex: F
Vaccine: HPV4
Symptoms: Echocardiogram, Pericardial effusion
Clinical narrative: Information has been received from a physician concerning a 14 year old female who on 01-MAY-2008 was vaccinated with the third dose of GARDASIL (lot # 0152X) and 3 weeks later (approximately 22-may-2008) was diagnosed with pericardial effusion.  At the time of reporting the patient was not recovered.  Lab diagnostics studies performed included echocardiogram.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Loss of consciousness, Sinusitis
Clinical narrative: Information has been received from a physician's assistant concerning a 13-15 year old female who on 08-JAN-2009 was vaccinated with the third dose of GARDASIL, and lost consciousness. It was also reported that the patient had a sinus infection. The patient sought unspecified medical attention. On the same day, the patient recovered. No further  information is available.
Age: 21.0
Sex: F
Vaccine: HPV4
Symptoms: Human papilloma virus test positive, Smear cervix abnormal
Clinical narrative: Information has been received from a 21 year old female with attention deficit disorder and no medical history who was vaccinated with three doses of GARDASIL on unspecified dates. Concomitant therapy included YAZ for birth control and Concerta for attention deficit disorder. On 30-DEC-2008 the patient administered a pap smear test which came back positive for HPV. The patient sought unspecified medical attention. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: No reaction on previous exposure to drug, Rash, Urticaria
Clinical narrative: Information has been received from a physician concerning a female who was vaccinated with a first dose of GARDASIL without any reactions and on 08-JAN-2009 was vaccinated with second dose of GARDASIL. Concomitant therapy included PLAN B which was given on 07-JAN-2009. Subsequently the patient experienced hives and rash. The patient was seen at the physician's office. At the time of reporting, the patient's hives and rash persisted. Additional information has been requested. This is in follow-up to report(s) previously submitted on 02/13/09. No further information was available.
Age: 21.0
Sex: U
Vaccine: HPV4
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Information has been received from a registered nurse concerning a 21 year old patient who on 10-NOV-2008 was vaccinated with a first dose of GARDASIL. Subsequently the patient experienced itching and redness at the injection site. On unknown date, the patient recovered from redness at the injection site. At the time of reporting, the patient's itching at the injection site persisted. The patient sought medical attention by contacting office. Additional information has been requested.
Age: 19.0
Sex: F
Vaccine: HPV4
Symptoms: Rash generalised, Rash pruritic
Clinical narrative: Information has been received from a 19 year old female with no known drug allergies who on 05-JAN-2009 was vaccinated with the third dose of GARDASIL vaccine. There was no concomitant medication. On 08-JAN-2009 the patient experienced a rash that originally appeared on one arm and then the other arm and was all over her body in small patches at time of the report. She stated the rash was extremely itchy. The patient did not perform any lab diagnostics studies. At time of the report the patient was not recovered. The patient sought medical attention via telephone. Additional information has been requested.
Age: 16.0
Sex: F
Vaccine: HPV4
Symptoms: Activities of daily living impaired, Drug administered at inappropriate site, Pain, Vaccine positive rechallenge
Clinical narrative: Information has been received from a nurse concerning a 16 year old female with no medical history of drug allergy who on 11-JUL-2008 was vaccinated with the first dose of GARDASIL (lot # 660557/0072X). 0.5ml, IM in her arm. Concomitant therapy included hormonal contraceptives (unspecified). On 11-JUL-2008 the patient experienced pain. The patient was a gymnast and the pain interfered with her performance at a competition the following day. The second dose was administered on 12-SEP-2008 in her gluteal muscle at the patient's request. The patient did not perform any lab diagnostics studies. At time of report the patient recovered. The patient did not seek medical attention. Follow-up information has been received from a nurse concerning the patient who received the third dose of GARDASIL in the arm on 15-JAN-2009. Subsequently the patient experienced soreness. At time of the report the outcome of the patient was unknown. The patient sought unspecified medical attention. This is one of several reports from the same source. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4
Symptoms: Drug exposure during pregnancy, Smear cervix abnormal, Ultrasound scan normal
Clinical narrative: Information has been received from a nurse practitioner, for GARDASIL, a Pregnancy Registry product, concerning a 17 year old female who on 03-JUL-2008 was vaccinated with the first dose of GARDASIL.  The patient has only been given the first dose of GARDASIL.  The patient was 5 weeks pregnant but has already started the GARDASIL vaccine series.  The patient had an abnormal PAP smear when she reported being pregnant but she already started the GARDASIL series.  The patient sought medical attention.  Additional information has been requested. Follow up information has been received from a nurse practitioner concerning a 17 year old female who was 36 weeks intrauterine pregnancy. The patient's LMP was 28-MAY-2008 and estimated delivery date was 05-MAR-2009. The patient had twice routine ultrasound on 06-OCT-2008 and 01-DEC-2008 respectively and the results were within normal limits. Additional information has been requested.
Sex: F
Vaccine: HPV4
Symptoms: Dizziness
Clinical narrative: Information has been received from a medical assistant concerning her daughter who was vaccinated with the first dose of GARDASIL on an unspecified date. Subsequently the patient experienced extreme dizziness. No further information provided. The outcome was unknown at time of reporting. Additional information has been requested. Follow up information was received froma aphysician via telephone call who verified he had never seen the reporter's daughter. He had never examined the patient  and had never administered GARDASIL vaccine(yeast) to her. There was no patient file on the patientAdditional information is not expected.
Sex: F
Vaccine: HPV4
Symptoms: Cervical dysplasia
Clinical narrative: Information has been received from a physician concerning a female patient who was vaccinated with three doses of GARDASIL vaccine (no lot number was provided). Subsequently the patient had been diagnosed with cervical dysplasia. At the time of this report, the outcome was unknown. The patient sought unspecified medical attention. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Dizziness, Headache, Nausea, Urticaria, Vomiting
Clinical narrative: Information has been received from a nurse practitioner concerning a 15 year female who in May 2008, was vaccinated with the first 0.5ml dose of GARDASIL lot#655327/1287U. Concomitant medication included YASMIN. Up to 4 months after receiving GARDASIL (Sep-2008), the patient experienced vomiting and a headache. It is unknown  whether patient will continue with the series however she has yet to receive the second dose. At the time of reporting (08-Jan-2009) the patient was recovered. The patient sought medical attention. Additional information has been requested. with the series however she has yet to receive the second dose. At the time of reporting (08-Jan-2009) the patient was recovered. The patient was recovered. The patient sought medical attention. Additional information has been requested. Follow up information was received from a Nurse Practitioner reporting that the 14 year old female patient was vaccinated in the right deltoid with the first dose of GARDASIL (lot# 655027/1287U) on 28-MAY-2008. The physician saw patient for the first time on 23-DEC-2008. It was reported that the patient had intermittent vomiting, dizziness, headache for 4 monoths after the first dose of vaccine. The patient also had intermittent hives in the left arm. Shot was given by previous office. The patient also had a birth control pill change the same time. The physician felt that this could have accounted for the patient's nausea and headaches. No relevant diagnostic tests or laboratory data was collected. The patient was recovered on an unspecified date. The patient sough medical attention. Additional information has been requested.
Age: 15.0
Sex: F
Vaccine: HPV4
Symptoms: Vaginal discharge
Clinical narrative: Information has been received from a consumer concerning her 15 year old daughter with no medical history and drug allergies, who in July 2008 was intramuscularly vaccinated with the third 0.5 ml dose of GARDASIL. There was no concomitant medication. Several weeks ago the patient experienced vaginal discharge and it was not itchy, painful or "smell". The patient's vaginal discharge came and went. At the time of reporting, the patient did not recover. The patient did not seek medical attention. Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Computerised tomogram head, Computerised tomogram normal, Headache, Injection site mass, Screaming
Clinical narrative: Information has been received from a nurse practitioner concerning an 18 year old female who was vaccinated with the second dose of GARDASIL intramuscularly 0.5mL in approximately September 2008 ("about 4 months ago").  There is no concomitant medication.  In approximately September 2008 ("within 24 hours of administration), the patient experienced severe headaches and had a large lump at the injection site.  She was found by her mother in bed holding her head, hollering and thrashing.  She was taken to the emergency room and had a scan of her head taken.  The test came back benign.  The headache lasted for about 5 days.  The patient recovered 5 days later after onset.  Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Headache, Injection site nodule, Scan brain, Screaming
Clinical narrative: Information has been received from a nurse practitioner concerning an 18 year old female who was vaccinated with the second dose of GARDASIL intramuscularly 0.5mL in approximately September 2008 ("about 4 months ago").  There is no concomitant medication.  In approximately September 2008 ("within 24 hours of administration), the patient experienced severe headaches and had a large lump at the injection site.  She was found by her mother in bed holding her head, hollering and thrashing.  She was taken to the emergency room and had a scan of her head taken.  The test came back benign.  The headache lasted for about 5 days.  The patient recovered 5 days later after onset.  Additional information has been requested.
Age: 17.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Computerised tomogram head, Computerised tomogram normal, Headache, Injection site mass, Screaming
Clinical narrative: This is in follow-up to report(s) previously submitted on 2/13/2009. Information has been received from a nurse practitioner concerning a 17 year old female patient with no pertinent medical history and no known drug allergies who on 02-JUL-2008, was vaccinated with the first 0.5 ml IM dose of GARDASIL into her left arm. On 03-SEP-2008 the patient received the second 0.5 ml IM dose of GARDASIL into her left arm. There was no concomitant medication. On 04-SEP-2008 the patient experienced severe headaches. The patient was found by her mother in bed holding her head, hollering and thrashing. The patient was taken to the emergency room and was treated with MOTRIN. A head scan was performed and the result was benign. The headaches lasted for five days. The patient also had granuloma (also reported as a large lump) at the injection site. On approximately 08-SEP-2008 ("5 days after onset"), the patient recovered from adverse events. VAERS number: 340738, 340728. This is a consolidation of two reports concerning the same patient. This is one of several reports from the same source. Additional information has been requested. It has been determined that WAES # 0901USA01005 is a duplicate of WAES # 0901USA00374. Therefore, WAES # 0901USA01005 is being deleted from our files and the reports consolidated into WAES # 0901USA00374.